You have 9 free searches left this month | for more free features.

Tumor Resection

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 2, 2021

Advanced or Metastatic Solid Tumor Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL97 for Injection)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • Recombinant Humanized Monoclonal Antibody MIL97 for Injection
  • Beijing, Beijing, China
    Chinese PLA General Hospital
May 26, 2022

Tumor Metastasis Trial in France, United States (Cryoablation)

Completed
  • Neoplasm Metastasis
  • Cryoablation
  • Los Angeles, California
  • +9 more
Jul 15, 2021

Post-operative Pain, Colon Cancer, Diverticulitis Trial in Des Moines (Bupivacaine, Bupivacaine liposome suspension)

Completed
  • Post-operative Pain
  • +2 more
  • Des Moines, Iowa
    Mercy Medical Center
Dec 14, 2020

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 25, 2022

Decipher® Testing - VANDAAM Study

Recruiting
  • Prostate Cancer
  • Decipher® Testing
  • Bay Pines, Florida
  • +2 more
May 27, 2022

Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer Trial in Fairfax (Drug determined by

Recruiting
  • Breast Cancer
  • +2 more
  • Drug determined by treating oncologist based on recommendation from systems biology analysis.
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Oct 13, 2021

Childhood Atypical Teratoid/Rhabdoid Tumor Trial in Australia, Canada, United States (radiation, procedure, drug, biological,

Active, not recruiting
  • Childhood Atypical Teratoid/Rhabdoid Tumor
  • 3-Dimensional Conformal Radiation Therapy
  • +11 more
  • Birmingham, Alabama
  • +93 more
Feb 25, 2022

Sarcoma Trial in Seattle (drug, other, biological)

Completed
  • Sarcoma
  • Doxorubicin Hydrochloride
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 3, 2021

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (drug, procedure, device)

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

Functional Popliteal Artery Entrapment Syndrome, Popliteal Artery Entrapment Syndrome Trial in Redwood City (Dysport)

Withdrawn
  • Functional Popliteal Artery Entrapment Syndrome
  • Popliteal Artery Entrapment Syndrome
  • Redwood City, California
    Stanford University
Mar 4, 2021

Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 10, 2022

Glioblastoma Trial in New York (Ketogenic Diet, Metformin)

Recruiting
  • Glioblastoma
  • New York, New York
  • +1 more
Dec 21, 2021

Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,

Active, not recruiting
  • Colon Adenocarcinoma
  • +8 more
  • Clobetasol Propionate
  • +3 more
  • Phoenix, Arizona
  • +21 more
Jan 5, 2022

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

Integrated Genomic Prostate Score With MRI Targeted Prostate

Active, not recruiting
  • Prostate Cancer
    • Birmingham, Alabama
    • +1 more
    Jan 12, 2023

    Rectal Cancer, Pathological Complete Response, Disease Free Survival Trial in Beijing (concurrent capecitabine-based long-term

    Unknown status
    • Rectal Cancer
    • +2 more
    • concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME
    • concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX
    • Beijing, Beijing, China
    • +1 more
    May 17, 2020

    Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,

    Recruiting
    • Glioblastoma
    • +2 more
    • Intensity-Modulated Radiation Therapy
    • Quality-of-Life
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021

    Lung Cancer Trial in France (biological, drug, procedure)

    Completed
    • Lung Cancer
    • filgrastim
    • +4 more
    • Besancon, France
    • +21 more
    Feb 19, 2021

    Benign Airway Stenosis, Respiratory Tract Fistula Trial in Guangzhou (Control group, SVF group)

    Recruiting
    • Benign Airway Stenosis
    • Respiratory Tract Fistula
    • Control group
    • SVF group
    • Guangzhou, Guangdong, China
      Guangzhou Institute of Respiratory Disease, The First Affiliated
    Mar 19, 2022

    Predictive Factors of Onset of Bone Metastases in Cancer

    Completed
    • Bone Metastases
      • Bagheria, Palermo, Italy
        Dipartimento Rizzoli Sicialia - Istituto Ortopedico Rizzoli
      Mar 21, 2022

      Malignant Melanoma, Lung Cancer, or Colorectal Cancer Trial in Suzhou (TAA06 injection)

      Recruiting
      • Malignant Melanoma, Lung Cancer, or Colorectal Cancer
      • TAA06 injection
      • Suzhou, Jiangsu, China
        PersonGen BioTherapeutics(Suzhou) Co., Ltd.
      Dec 29, 2021

      Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial in China, Spain, United States (FCN-159)

      Recruiting
      • Neurofibromatosis 1
      • +2 more
      • Los Angeles, California
      • +11 more
      Jul 25, 2022

      Breast Cancer Trial in Dallas (LA TNBC: DC vaccine+Preop chemo, ER+/HER2-BC:DC vaccine+Preop chemo)

      Completed
      • Breast Cancer
      • LA TNBC: DC vaccine+Preop chemo
      • ER+/HER2-BC:DC vaccine+Preop chemo
      • Dallas, Texas
        Baylor University Medical Center
      Oct 7, 2021

      Oral Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Carrimycin)

      Active, not recruiting
      • Oral Squamous Cell Carcinoma
      • Head and Neck Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
      May 13, 2021